Cardiovascular disease is a major cause of morbidity and mortality in patients with impaired renal function dyslipidemia has been established as a well known traditional risk factor for cardiovascular disease cvd in the general population and it is well known that patients with chronic kidney disease ckd exhibit significant alterations in lipoprotein metabolism. Kidney disease improving quality outcomes kdoqi published guidelines for the management of dyslipidemia in ckd in the american journal of kidney diseases in april 2003 however these guidelines were written before the results of some major clinical trials were published including the assessment of lescol in renal transplantation die . Adapted from kidney disease outcomes quality initiative k doqi group k doqi clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Kidney disease improving global outcomes prevalence of dyslipidemias in ckd major determinants of dyslipidemia in ckd o gfr o dm o proteinuria o immunosuppressive agents o method of renal replacement o co morbidity o dyslipidemia is common in people with ckd but
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )